Topotecan and the development of scleroderma or a scleroderma-like illness

被引：5

作者：

Ene-Stroescu, D ^{[1
]}

Ellman, MH

Peterson, CE

机构：

[1] Univ Chicago, Chicago, IL 60637 USA

[2] Joliet Oncol Hematol Associates, Joliet, IL USA

来源：

ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 03期

关键词：

D O I：

10.1002/art.10098

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：844 / 845

页数：2

共 11 条

[1]

Abang AM, 1998, SEMIN HEMATOL, V35, P13

[2] Topotecan - A review of its potential in advanced ovarian cancer [J].

Brogden, RN ;

Wiseman, LR .

[3]

DOUVAS A, 1988, LANCET, V2, P475

Dziegielewski, J ;

Melendy, T ;

Beerman, TA .

[5]

Gussin HAE, 2001, ARTHRITIS RHEUM, V44, P376

[6]

Henry PA, 2000, ARTHRITIS RHEUM-US, V43, P2733, DOI 10.1002/1529-0131(200012)43:12<2733::AID-ANR13>3.0.CO

[7]

2-G

[8]

Kuwana M, 2000, ARTHRITIS RHEUM-US, V43, P1074, DOI 10.1002/1529-0131(200005)43:5<1074::AID-ANR18>3.0.CO

[9]

2-E

[10]

SILVER M, 2001, ARTHRITIS ALLIED CON, P1625